CF Patients' COVID antibodies tracked in new study
NCT ID NCT05054582
First seen Feb 02, 2026 · Last updated May 15, 2026 · Updated 8 times
Summary
This study looked at whether people with cystic fibrosis (CF) have COVID-19 antibodies and how their bodies respond to the virus or the vaccine. Over two years, 152 adults and children with CF from European clinics gave blood samples to check for antibodies. The goal was to understand why fewer CF patients get severe COVID-19 and how their immune system reacts.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CF Centre Innsbruck, Medical University of Innsbruck, Univ. Clinic for Paediatics III
Innsbruck, Tyrol, 6020, Austria
Conditions
Explore the condition pages connected to this study.